Nebulized therapies in COPD: past, present, and the future

IZ Barjaktarevic, AP Milstone - International journal of chronic …, 2020 - Taylor & Francis
Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …

Future trends in nebulized therapies for pulmonary disease

SD McCarthy, HE González, BD Higgins - Journal of Personalized …, 2020 - mdpi.com
Aerosol therapy is a key modality for drug delivery to the lungs of respiratory disease
patients. Aerosol therapy improves therapeutic effects by directly targeting diseased lung …

Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease

SP Bhatt, A Agusti, M Bafadhel… - American Journal of …, 2023 - atsjournals.org
Chronic obstructive pulmonary disease is a major health problem with a high prevalence, a
rising incidence, and substantial morbidity and mortality. Its course is punctuated by acute …

Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2‐agonists

MI MacDonald, KR Polkinghorne, CJ MacDonald… - …, 2023 - Wiley Online Library
Abstract Background and Objective Raised blood lactate secondary to high dose β2‐agonist
treatment has been reported in asthma exacerbations but has not been investigated during …

[PDF][PDF] Efektivitas Pengobatan pada Pasien Penyakit Paru Obstruksi Kronis (PPOK) di Rumah Sakit Wilayah Yogyakarta

CP Sari, S Hanifah, R Rosdiana… - Jurnal Manajemen Dan …, 2021 - academia.edu
ABSTRAK Penyakit Paru Obstruksi Kronik (PPOK) merupakan gangguan pernafasan
kompleks yang memerlukan berbagai macam pendekatan untuk menilai respon …

Managing exacerbations of COPD: how much progress have we made?

F Baraldi, M Barrecheguren, A Papi… - COPD in the 21st …, 2024 - books.google.com
The pharmacological treatment of exacerbations of COPD has not significantly changed in
the last decades. The use of short-acting bronchodilators to improve symptoms, systemic …

Nonantibiotic pharmacological treatment of severe chronic obstructive pulmonary disease exacerbations

F Vasques, L Camporota… - Seminars in Respiratory …, 2020 - thieme-connect.com
Severe, acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a
rapid deterioration of the respiratory symptoms of patients with COPD, requiring hospital …

The effect of albuterol spray on hypoxia and bronchospasm in patients with chronic obstructive pulmonary disease (COPD) under general anesthesia: a bouble-blind …

SA Maddah, A Barzegari - Ethiopian Journal of Health Sciences, 2023 - ajol.info
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) experience
an increased risk of perioperative pulmonary complications. The aim of this study was to …

Revefenacin for the treatment of chronic obstructive pulmonary disease

F Li, J Yang - Expert Review of Clinical Pharmacology, 2019 - Taylor & Francis
Introduction: Acetylcholine is the predominant parasympathetic neurotransmitter in the
airways, and plays a key role in the pathophysiology of chronic obstructive pulmonary …

The Management of Acute Exacerbations in COPD: A Retrospective Observational Study and Clinical Audit

M Boesing, N Ottensarendt, G Lüthi-Corridori… - Journal of Clinical …, 2023 - mdpi.com
(1) Background: Acute exacerbations of chronic obstructive pulmonary disease (COPD) are
not only associated with increased patient morbidity and mortality, but with extensive …